I just came across this little blurb in the MS Society Winter 2009 newsletter:
Tysabri reimbursement
On July 1, 2009, Alberta and Saskatchewan
agreed to cover most of the cost of Tysabri
(natalizumab) for people with MS, who have
failed on two other disease-modifying therapies.
As of September 30, Ontario agreed to reimburse
Tysabri for the treatment of Rapidly Evolving
Severe Relapsing-Remitting multiple sclerosis
(RES-RRMS) in individuals who meet certain
criteria. This brings the total to four provinces
that are now reimbursing Tysabri, with Quebec
having agreed to cover the drug last year.
The MS Society looks forward to other provinces
following suit with this reimbursement and
will continue advocacy with other provincial
governments in the hopes to see this realized.